Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：111

作者：

Oberg, K. ^{[1
]}

Akerstrom, G. ^{[2
]}

Rindi, G. ^{[3
]}

Jelic, S. ^{[4
]}

机构：

[1] Univ Uppsala Hosp, Dept Endocrine Oncol, Uppsala, Sweden

[2] Univ Uppsala Hosp, Dept Surg, S-75185 Uppsala, Sweden

[3] UCSC Policlin A Gemelli, Inst Pathol, Rome, Italy

[4] Inst Oncol & Radiol, Internal Med Serv, Belgrade, Serbia

来源：

ANNALS OF ONCOLOGY | 2010年 / 21卷

关键词：

PROGNOSTIC-FACTORS; BIOTHERAPY; SURVIVAL; THERAPY; GENE;

D O I：

10.1093/annonc/mdq192

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：v223 / v227

页数：5

共 19 条

[1] Surgery on neuroendocrine tumours [J].

Akerstrom, Goran ;

Hellman, Per .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) :87-109

[2] Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].

Chandrasekharappa, SC ;

Guru, SC ;

Manickam, P ;

Olufemi, SE ;

Collins, FS ;

EmmertBuck, MR ;

Debelenko, LV ;

Zhuang, ZP ;

Lubensky, IA ;

Liotta, LA ;

Crabtree, JS ;

Wang, YP ;

Roe, BA ;

Weisemann, J ;

Boguski, MS ;

Agarwal, SK ;

Kester, MB ;

Kim, YS ;

Heppner, C ;

Dong, QH ;

Spiegel, AM ;

Burns, AL ;

Marx, SJ .

SCIENCE, 1997, 276 (5311) :404-407

[3] Tumor markers in neuroendocrine tumors [J].

Eriksson, B ;

Öberg, K ;

Stridsberg, M .

DIGESTION, 2000, 62 :33-38

[4]

KLOPPEL G, 2008, NEUROENDOCRINOL 1205

[5] IDENTIFICATION OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE [J].

LATIF, F ;

TORY, K ;

GNARRA, J ;

YAO, M ;

DUH, FM ;

ORCUTT, ML ;

STACKHOUSE, T ;

KUZMIN, I ;

MODI, W ;

GEIL, L ;

SCHMIDT, L ;

ZHOU, FW ;

LI, H ;

WEI, MH ;

CHEN, F ;

GLENN, G ;

CHOYKE, P ;

WALTHER, MM ;

WENG, YK ;

DUAN, DSR ;

DEAN, M ;

GLAVAC, D ;

RICHARDS, FM ;

CROSSEY, PA ;

FERGUSONSMITH, MA ;

LEPASLIER, D ;

CHUMAKOV, I ;

COHEN, D ;

CHINAULT, AC ;

MAHER, ER ;

LINEHAN, WM ;

ZBAR, B ;

LERMAN, MI .

SCIENCE, 1993, 260 (5112) :1317-1320

[6] A 5-decade analysis of 13,715 carcinoid tumors [J].

Modlin, IM ;

Lye, KD ;

Kidd, M .

CANCER, 2003, 97 (04) :934-959

[7] Chemotherapy and biotherapy in the treatment of neuroendocrine tumours [J].

Öberg, K .

ANNALS OF ONCOLOGY, 2001, 12 :S111-S114

[8] Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization [J].

Panzuto, F ;

Nasoni, S ;

Falconi, M ;

Corleto, VD ;

Capurso, G ;

Cassetta, S ;

Di Fonzo, M ;

Tornatore, V ;

Milione, M ;

Angeletti, S ;

Cattaruzza, MS ;

Ziparo, V ;

Bordi, C ;

Pederzoli, P ;

Delle Fave, G .

[9] Biotherapy [J].

Ploeckinger, U. ;

Wiedenmann, B. .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (01) :145-162

[10] TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system [J].

Rindi, G. ;

Kloeppel, G. ;

Alhman, H. ;

Caplin, M. ;

Couvelard, A. ;

de Herder, W. W. ;

Erikssson, B. ;

Falchetti, A. ;

Falconi, M. ;

Komminoth, P. ;

Koerner, M. ;

Lopes, J. M. ;

McNicol, A-M. ;

Nilsson, O. ;

Perren, A. ;

Scarpa, A. ;

Scoazec, J. -Y ;

Wiedenmann, B. .

VIRCHOWS ARCHIV, 2006, 449 (04) :395-401

← 1 2 →